Conditions: Anemia Chronic Renal Insufficiency
Keywords: Treatment associated with CRI
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 337
Healthy volunteers: no

Brief summary:
This is a randomized, controlled, double-blind, multicenter multinational safety study involving about 300 predialysis patients aged 18 years or above suffering from anemia.

Symptomatic anemia will be corrected by s.c. application of EPO HEXAL or ERYPO® in order to achieve a hemoglobin target range of 10.0 -12.0 g/dL.

Detailed description:

Arms:
arm 1: HX575, EPO HEXAL arm 2: ERYPO

Interventions: intervention 1: HX575 recombinant human erythropoietin alfa intervention 2: ERYPO
Intervention descriptions: intervention 1: Solution for injection (s.c.) intervention 2: Solution for injection (s.c.)

Protocol document: